October 16, 2014 Chicago, IL

Agenda

Get Notified When the Agenda Gets Updated!

Fill out my online form.

Thursday, November 14th, 2013

6:30 - 7:30 amRegistration Check-in and Breakfast
7:30 -7:45 amWelcome and Chairman’s Opening Remarks, Followed by "2013; Year in Review"

Emmett T. Cunningham Jr. MD PhD MPH, Partner - Clarus Ventures
Gilbert Kliman MD, Managing Director - InterWest Partners
William J. Link PhD, Managing Director - Versant Ventures

7:45 - 9:21 am Private Device Company Showcase

Co-Moderators:
Murthy V. Simhambhatla PhD, Senior Vice President - Abbott Medical Group
James Garvey, Chairman & Managing Partner - SV Life Sciences

7:45 - 7:53 i-Optics Corporation Jeroen Cammeraat, CEO
7:53 - 8:01 Notal Vision Scott Jones, President
8:01 - 8:09 Clarity Medical Keith Mullowney, Chairman & CEO
8:09 - 8:17 WaveTec Vision Systems Thomas Frinzi, President & CEO
8:17 - 8:25 Refocus Group Mike Judy, President & CEO
8:25 - 8:33 PowerVision Barry Cheskin, President & CEO
8:33 - 8:41 AkkoLens International BV Michiel Rombach, CEO
8:41 - 8:49 AcuFocus Nicholas Tarantino OD, Chief Clinical & Regulatory Officer
8:49 - 8:57 ClarVista Medical Paul McLean, President & CEO
8:57 - 9:05 Sinopsys Surgical Harry Ross, President & CEO
9:05 - 9:13 Sensimed AG Jean-Marc Wismer, CEO
9:13 - 9:21 Avedro David Muller PhD, President & CEO


9:21 - 9:50 amMorning Refreshment and Networking Break

9:50 - 11:34 amPrivate BioPharma Company Showcase

Co-Moderators:
Theresa GH Heah MD, Director of Brand Management & Global Marketing Ophthalmology - Bayer HealthCare Pharmaceuticals
Neil Levine, Sr. Director, Marketing – Regeneron Pharmaceuticals

9:50 - 9:58 Aerie Pharmaceuticals Vicente Anido Jr. PhD, Chairman & CEO
9:58 - 10:06 Amakem Therapeutics Jack Elands, CEO
10:06 - 10:14 Ocular Therapeutix Amarpreet Sawhney, President & CEO
10:14 - 10:22 RXi Pharmaceuticals Geert Cauwenbergh, President & CEO
10:22 - 10:30 Ophthotech Corporation David Guyer, CEO
10:30 - 10:38 Neurotech Ted Danse, President & CEO
10:38 - 10:46 Allegro Ophthalmics Vicken Karageozian, Co-Founder & CTO
10:46 - 10:54 PanOptica Paul Chaney , President & CEO
10:54 - 11:02 iCo Therapeutics Andrew Rae, President & CEO
11:02 - 11:10 Novaliq GmbH Bernhard Günther, CEO
11:10 - 11:18 Eleven Biotherapeutics Abbie Celniker, CEO
11:18 - 11:26 Icon BioSciences William S. (Sandy) White, President & CEO
11:26 - 11:34 Kala Pharmaceuticals Guillaume Pfefer, President & CEO


11:34 -11:59 am Mobile Ophthalmic Technology Showcase

Moderator:
Gilbert Kliman MD, Managing Director – InterWest Partners

11:34 - 11:39 Gobiquity Mobile Health Michael Brownell, CEO
11:39 - 11:44 Digisight Doug Foster, CEO
11:44 - 11:49 CheckedUp Richard Awdeh MD, Founder & CEO
11:49 - 11:54 EyeNetra David Schafran, Co-Founder & COO
11:54 - 11:59 KeepYourSight Marie Alexander, CEO


11:59 -12:06 pmThe Ophthalmology Market – "A View from the Public Sector”

Jeffrey Hoffman, Managing Director, Head of West Coast Healthcare Investment Banking – JPMorgan

12:06 -12:13 pmPrivate Funding and Exit Trends

Jonathan Norris, Managing Director - SVB Capital

12:13 -12:20 pmUS vs. EU – A Venture Perspective

William J. Link PhD, Managing Director - Versant Ventures

12:20 pmLuncheon Commences

1:00 - 1:25 pmKeynote: Sustaining Innovation in Ophthalmology - “A View From the Top”

David E.I. Pyott, Chairman of the Board & CEO - Allergan

1:25 - 1:50 pmOIS Innovator Award

Recipients:
Thomas Burns, President & CEO - Glaukos
Richard Hill MD, Co-Founder - Glaukos
1:50 - 2:00 pmCoffee and Networking

2:00 pmLuncheon Concludes

2:00 - 2:07 pmOphthalmic Innovation 2013 – “A View from the NEI”

Paul Sieving MD, Director - National Eye Institute, National Institutes of Health

2:07 - 2:15 pmOphthalmic Innovation 2013 – “A View from the AAO”

David W. Parke MD, CEO - American Academy of Ophthalmology

2:15 - 2:50 pmDeveloping an Effective Dialogue with the FDA

Moderator:
Emmett T. Cunningham Jr. MD PhD MPH, Partner - Clarus Ventures

Panel Members:
Wiley A. Chambers MD, Deputy Director of the Division of Transplant and Ophthalmology Products, Center for Drug Evaluation and Research - FDA
Malvina B. Eydelman MD, Director, Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices Office, Device Evaluation Center of Devices and Radiological Health - FDA
2:50 - 3:20 pmAlternative Financing Strategies

Moderator:
Charles Warden, Managing Director - Versant Ventures

Panel Members:
Luke Duster, Principal - Capital Royalty
Gregory Shearer, Managing Director - Healthios Capital Markets
Brian Demmert, Managing Partner - Armentum Partners
Buzz Benson, Managing Director - Sightline Partners
3:20 - 3:50 pmEU Commercialization Strategies

Moderator:
Gilbert Kliman MD, Managing Director - InterWest Partners

Panel Members:
Laurent Attias, Head, Global Commercial Strategy - Alcon
David Muller, President & CEO - Avedro
David E.I. Pyott, Chairman of the Board & CEO - Allergan
James Mazzo, Operating Partner - Versant Ventures (Chairman - AcuFocus)
Andy Corley, Venture Partner - Versant Ventures

3:50 - 4:20 pmAfternoon Refreshment and Networking Break

4:20 - 5:00 pmPhysician Entrepreneurship in Ophthalmology

Moderator:
Richard L. Lindstrom MD, Founder & Attending Surgeon - Minnesota Eye Consultants

Panel Members:
Mark S. Blumenkranz MD, Professor & Chairman of the Department of Ophthalmology - Stanford University
Eugene de Juan MD, Founder & Vice Chairman - ForSight Labs
David L. Epstein MD MMM, Joseph A.C. Wadsworth Clinical Professor of Ophthalmology & Chairman of Duke Eye Center - Duke University School of Medicine
Steve Charles MD, CEO - CamPlex
Daniel Durrie MD, Founder & President - Durrie Vision

5:00 - 5:30 pmGoing Public – Who, When, and Why?

Moderator:
David R. Guyer MD, Chief Executive Officer - Ophthotech

Panel Members:
Jeffrey Hoffman, Managing Director, Head of West Coast Healthcare Investment Banking – JPMorgan
Dan Myers, Co-Founder, President & CEO - Alimera Sciences
Nicholas Galakatos PhD, Managing Director - Clarus Ventures
David E. Redlick, Partner & Co-Chair of the Life Sciences Group – WilmerHale
Chris Cooley CFA, Managing Director - Stephens

5:30 - 5:35 pmWrap Up and Closing Comments

Emmett Cunningham Jr. MD PhD MPH, Partner - Clarus Ventures
Gilbert Kliman MD, Managing Director - InterWest Partners
William J. Link PhD, Managing Director - Versant Ventures

5:35 - 7:00 pmNetworking Reception